101 related articles for article (PubMed ID: 16929455)
1. [Optimizing the antipsychotic potency of olanzapine by augmentation--a critical review].
Zink M
Psychiatr Prax; 2006 Sep; 33(6):261-8. PubMed ID: 16929455
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of olanzapine in treatment-resistant schizophrenia.
Zink M
J Psychiatry Neurosci; 2005 Nov; 30(6):409-15. PubMed ID: 16327874
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy in schizophrenia.
Baandrup L
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):183-192. PubMed ID: 31908124
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
5. [Polypharmacy in schizophrenia].
Zink M; Englisch S; Meyer-Lindenberg A
Nervenarzt; 2011 Jul; 82(7):853-8. PubMed ID: 21165589
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive treatment of acute mania: a clinical overview.
Sachs GS; Gardner-Schuster EE
Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
[TBL] [Abstract][Full Text] [Related]
7. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
Lerner V; Libov I; Kotler M; Strous RD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
[TBL] [Abstract][Full Text] [Related]
8. [Augmenting atypical antipsychotic medications with clozapin].
Zink M; Dressing H
Nervenarzt; 2005 Sep; 76(9):1092, 1094-8, 1100-2. PubMed ID: 15782324
[TBL] [Abstract][Full Text] [Related]
9. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
Dold M; Li C; Gillies D; Leucht S
Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
[TBL] [Abstract][Full Text] [Related]
11. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
12. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.
Kelly DL; Conley RR; Feldman S; Yu Y; McMahon RP; Richardson CM
Psychiatr Q; 2006; 77(1):81-95. PubMed ID: 16397757
[TBL] [Abstract][Full Text] [Related]
13. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
14. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
15. [Akathisia in the course of olanzapine treatment].
Makkos Z; Csonka A
Neuropsychopharmacol Hung; 2006 Dec; 8(4):215-7. PubMed ID: 17211056
[TBL] [Abstract][Full Text] [Related]
16. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
[TBL] [Abstract][Full Text] [Related]
17. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
18. Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.
Citrome L; Levine J; Allingham B
Psychiatr Serv; 2000 May; 51(5):634-8. PubMed ID: 10783182
[TBL] [Abstract][Full Text] [Related]
19. [Olanzapine (Zyprexa)--reliable in acute treatment, prevention of recurrence and long-term mood stabilization].
Grunze H
Krankenpfl J; 2003; 41(10-12):225. PubMed ID: 14746204
[No Abstract] [Full Text] [Related]
20. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia.
Chiu YH; Hsu CY; Lu ML; Chen CH
Curr Pharm Des; 2020; 26(2):218-227. PubMed ID: 31924152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
